Nothing Special   »   [go: up one dir, main page]

MA et al., 2011 - Google Patents

Effect of adenosine 5-triphosphate on cell cycle of human acute myeloid leukemia KG1 cells during S phase

MA et al., 2011

Document ID
18127844437538924322
Author
MA M
Ahmadi A
et al.
Publication year

External Links

Snippet

ABSTRACT Adenosine 5-triphosphate [ATP] not only is the current energy source of all cells but also plays critical role in triggering signaling pathways leading to apoptosis or differentiation. In recent years many investigations have reported anti-cancer activity of ATP …
Continue reading at pesquisa.bvsalud.org (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine

Similar Documents

Publication Publication Date Title
ECSP21029576A (en) DERIVATIVES OF AZITHROMYCIN AND ROXITROMYCIN AS SENOLYTIC DRUGS
MA et al. Effect of adenosine 5-triphosphate on cell cycle of human acute myeloid leukemia KG1 cells during S phase
MA et al. Apoptosis induction and S-phase cell cycle arrest by adenosine 5-triphosphate through its degradation to adenosine in human myeloid leukemia K562 cell line
Jeong et al. The effects on self-care knowledge and performance in the individualized education for chemotherapy
OUYANG Docetaxel inhibits the migration and invasion of breast cancer cells by suppressing filopodia formation
Seyed Mohammad Amin et al. Growth inhibitory and differentiating effects of ethyl acetate soluble metabolite of Iranian native bacteria, Streptomyces calvus, in human myeloid leukemia K562 cell line
Cui et al. Idarubicin in combination with Ara-C and VP16 for treatment of refractory acute myelocytic leukemia
ZHOU Inhibition effect of extractum robinia-living trametes combined with chemotherapy on proliferation of gastric cancer cell MGC803 in vitro
Liu et al. Effects of endothelin-1 on the adhesion and expression of intercellular adhesion molecule 1 by A375 human malignant melanoma cells
Yin et al. Effect of low-dose decitabine in combination with imatinib mesylate in K562 cells
Shi et al. Purified protein derivatives tuberculin from virulent or attenuated strains of Mycobacterium tuberculosis induces cell death of human macrophages in different manner
Han et al. Chinicd Effect of acute Cerebral Infarction Treated with FDP
Abbas et al. Heat-treated tumor lysate loaded lymphoide dendritic cells: Evaluation of cytotoxic effect in the tumor bearing mice
Zou et al. Vitamin D induces nitric oxide production in cultured endothelial cells
Gao et al. The sonodynamic effect of chlorin-e6 on the proliferation of human breast cancer cells MDA-MB-231
Gong et al. Function of OTUD7B in acute myeloid leukemia cells and its mechanism
Wei-qiang et al. Selective targeting p53WT lung cancer cells harboring homozygous p53 Arg72 by an inhibitor of CypA
Gao et al. Effect of oxymatrine treatment on the invasion of human cervical cancer cells
Liu et al. Chemotherapy plus pirarubicin in treatment of malignant lymphoma in the elderly: an analysis of 50 cases
Leng et al. The Effect of New Photosensitizer Combined with Adriamycin on Cell Proliferation and Cell Cycle
LI et al. Rituximab in combination with conformal radiotherapy treatment of postoperative primary central nervous system lymphoma
LI et al. Role of HIF-1αin quinolinic acid-induced injury in PC12 cells
Liu et al. Molecular mechanism of synergistic antitumor activity and induced apoptosis of zoledronic acid and paclitaxel
Hajar et al. < The> effect of vitamin E and dexamethasone co-administration on varicocle-induced biochemical and histological alterations of liver in rats
Liu et al. Clinical study of gemcitabine plus cisplatin combined with in the treatment of advanced non-Small cell lung cancer